Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases.
Naomi J PatelClaire CookKathleen VanniXiaoqing FuXiaosong WangYumeko KawanoGrace QianBuuthien HangShruthi SrivatsanEmily P BanasiakEmily KowalskiKatarina BadeYuqing ZhangJeffrey A SparksZachary Scott WallacePublished in: Annals of the rheumatic diseases (2022)
Vaccinated patients with SARDs were less likely to experience PASC compared with those not fully vaccinated. While we cannot rule out the possibility that findings may be due to intrinsic differences in PASC risk from different SARS-CoV-2 variants, these findings support the benefits of vaccination for patients with SARDs and suggest that the immune response to acute infection is important in the pathogenesis of PASC in patients with SARDs.